ANI Pharmaceuticals, Inc.

Contributing Author

Recent Articles by ANI Pharmaceuticals, Inc.

Oct-24	ANI Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 7, 2025, at 8:30 a.m. ET ANIP GlobeNewswire
Oct-16	ANI Pharmaceuticals Announces NEW DAY Clinical Trial Results to be Presented in Late-Breaking Oral Presentation at the American Academy of Ophthalmology 2025 Meeting ANIP GlobeNewswire
Aug-25	ANI Pharmaceuticals to Present at Upcoming Investor Conferences ANIP GlobeNewswire
Aug-08	ANI Pharmaceuticals Reports Record Second Quarter 2025 Financial Results and Raises 2025 Guidance ANIP GlobeNewswire
Aug-01	ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ET ANIP GlobeNewswire
Jul-23	ANI Pharmaceuticals Announces Results from NEW DAY Clinical Trial of ILUVIEN for Use in Patients with Diabetic Macular Edema (DME) ANIP GlobeNewswire
Jul-02	ANI Pharmaceuticals to Participate at Leerink Partners Therapeutics Forum: I&I and Metabolism on July 8th ANIP GlobeNewswire
Jun-12	ANI Pharmaceuticals Announces Presentation of New Preclinical Data ANIP GlobeNewswire
May-27	ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference ANIP GlobeNewswire
May-22	ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin Gel for the Treatment of Acute Gout Flares ANIP GlobeNewswire
May-12	ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ ANIP GlobeNewswire
May-09	ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance ANIP GlobeNewswire
May-05	ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model ANIP GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.